Recently Viewed
Clear All
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
₹24,500 Cr
629.82
3.1
37.17
0.58
0.24 %
5.07 %
0.06 %
59.56
0.4
₹--
₹--
₹--
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
---|---|---|---|---|---|---|---|
Piramal Pharma
| -30.55 | -20.52 | -28.80 | 37.22 | -- | -- | -- |
BSE Healthcare
| -11.69 | -6.28 | -6.00 | 12.99 | 17.86 | 22.52 | 9.66 |
BSE Mid Cap
| -14.35 | -6.28 | -9.92 | 2.49 | 17.89 | 20.27 | 13.97 |
2024
|
2023
|
|
---|---|---|
Piramal Pharma
| 92.17 | 24.01 |
BSE Mid Cap
| 25.84 | 45.53 |
BSE Healthcare
| 43.09 | 36.97 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
--
--Min --Median --Max
--
--Min --Median --Max
--
Earnings Yield (%) = EBIT / Enterprise value
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | P/E Ratio | ROE |
---|---|---|---|---|
1,323.05 | 37,286.93 | -- | -15.04 | |
546.20 | 29,472.84 | 147.17 | 4.86 | |
1,089.65 | 27,701.76 | 99.21 | 13.86 | |
690.35 | 27,803.23 | 55.44 | 11.04 |
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India.... Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited. Read more
2020
Nandini Piramal
--
Mumbai, Maharashtra
The total asset value of Piramal Pharma Ltd stood at ₹ 15,242 Cr as on 31-Dec-24
The share price of Piramal Pharma Ltd is ₹184.90 (NSE) and ₹184.80 (BSE) as of 14-Feb-2025 IST. Piramal Pharma Ltd has given a return of 37.22% in the last 1 years.
Piramal Pharma Ltd has a market capitalisation of ₹ 24,500 Cr as on 14-Feb-2025. As per Value Research classification, it is a Mid Cap company.
The P/B ratio of Piramal Pharma Ltd is 3.10 times as on 14-Feb-2025, a 11% discount to its peers’ median range of 3.48 times.
The P/E ratio of Piramal Pharma Ltd is 629.82 times as on 14-Feb-2025, a 1594% premium to its peers’ median range of 37.17 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Piramal Pharma Ltd and enter the required number of quantities and click on buy to purchase the shares of Piramal Pharma Ltd.
Piramal Pharma Limited operates as a pharmaceutical company. It sells a portfolio of pharma products, as well as provides various pharma services, including injection, HPAPI, etc. The company was incorporated in 2020 and is based in Mumbai, India. Piramal Pharma Limited operates as a subsidiary of Piramal Enterprises Limited.
The prominent promoters of Piramal Pharma Ltd. are
Name of promoters | Holding percentage |
---|---|
The Sri Krishna Trust through its Trustee Mr. Ajay G Piramal and Dr. (Mrs.) Swati A Piramal |
26.62%
|
V3 Designs LLP |
3.25%
|
PRL Realtors LLP |
3%
|
The chairman of the company is Nandini Piramal, and the managing director is .
There is no promoter pledging in Piramal Pharma Ltd.
Some of the close peers are:
Company | Market Cap(₹ Cr) |
---|---|
37,287
|
|
29,473
|
|
27,803
|
|
27,702
|
Piramal Pharma Ltd. | Ratios |
---|---|
Return on equity(%)
|
0.67
|
Operating margin(%)
|
7.2
|
Net Margin(%)
|
-0.33
|
Dividend yield(%)
|
0.06
|
Yes, TTM profit after tax of Piramal Pharma Ltd was ₹39 Cr.